Ouvrages publiés en collaboration (1)
  1. 1. Rosiere, R., Amighi, K., & Wauthoz, N. (2019). Nanotechnology-based targeted drug delivery systems for lung cancer: Nanomedicine-based inhalation treatments for lung cancer.
    2.   Articles dans des revues avec comité de lecture (19)
  2. 1. Davenne, T., Percier, P., Larbanoix, L., Moser, M., Leo, O., Meylan, E., Goriely, S., Gérard, P., Wauthoz, N., Laurent, S., Amighi, K., & Rosiere, R. (2022). Inhaled dry powder cisplatin increases antitumour response to anti-PD1 in a murine lung cancer model. Journal of controlled release, 353, 317-326. doi:10.1016/j.jconrel.2022.11.055
  3. 2. Chraibi, S., Rosiere, R., De Prez, E., Gérard, P., Antoine, M.-H., Langer, I., Nortier, J., Remmelink, M., Amighi, K., & Wauthoz, N. (2021). Preclinical tolerance evaluation of the addition of a cisplatin-based dry powder for inhalation to the conventional carboplatin-paclitaxel doublet for treatment of non-small cell lung cancer. Biomedicine & pharmacotherapy, 139, 111716. doi:10.1016/j.biopha.2021.111716
  4. 3. Chraibi, S., Rosiere, R., Larbanoix, L., Gérard, P., Hennia, I., Laurent, S., Vermeersch, M., Amighi, K., & Wauthoz, N. (2021). The combination of an innovative dry powder for inhalation and a standard cisplatin-based chemotherapy in view of therapeutic intensification against lung tumours. European journal of pharmaceutics and biopharmaceutics, 164, 93-104. doi:10.1016/j.ejpb.2021.04.018
  5. 4. Chraibi, S., Rosiere, R., De Prez, E., Antoine, M.-H., Remmelink, M., Langer, I., Nortier, J., Amighi, K., & Wauthoz, N. (2021). Pulmonary and renal tolerance of cisplatin-based regimens combining intravenous and endotracheal routes for lung cancer treatment in mice. International journal of pharmaceutics, 599, 120425. doi:10.1016/j.ijpharm.2021.120425
  6. 5. Wauthoz, N., Rosiere, R., & Amighi, K. (2020). Inhaled cytotoxic chemotherapy: clinical challenges, recent developments, and future prospects. Expert opinion on drug delivery. doi:10.1080/17425247.2021.1829590
  7. 6. Van Der Westhuyzen, A. A., Ingels, A., Rosiere, R., Amighi, K., Oberer, L., Gustafson, K. K., Wang, D., Evidente, A., Maddau, L., Masi, M., De Villiers, A., Green, I. R., Berger, W., Kornienko, A., Mathieu, V., & Van Otterlo, W. W. (2020). Deciphering the chemical instability of sphaeropsidin A under physiological conditions-degradation studies and structural elucidation of the major metabolite. Organic & biomolecular chemistry, 18(40), 8147-8160. doi:10.1039/d0ob01586e
  8. 7. Nieto-Orellana, A., Li, H., Rosiere, R., Wauthoz, N., Williams, H., Monteiro, C. J., Bosquillon, C., Childerhouse, N., Keegan, G., Coghlan, D., Mantovani, G., & Stolnik, S. (2019). Targeted PEG-poly(glutamic acid) complexes for inhalation protein delivery to the lung. Journal of controlled release, 316, 250-262. doi:10.1016/j.jconrel.2019.10.012
  9. 8. Rosiere, R., Berghmans, T., De Vuyst, P., Amighi, K., & Wauthoz, N. (2019). The position of inhaled chemotherapy in the care of patients with lung tumours: clinical feasibility and indications according to recent pharmaceutical progresses. Cancers, 11(329), 1-13. doi:10.3390/cancers11030329
  10. 9. Rosiere, R., Hureaux, J., Levet, V., Amighi, K., & Wauthoz, N. (2018). La chimiothérapie inhalée – partie 2 : clinique et applications potentielles. Revue des maladies respiratoires, 35(4), 378-389. doi:10.1016/j.rmr.2018.02.002
  11. 10. Rosiere, R., Hureaux, J., Levet, V., Amighi, K., & Wauthoz, N. (2018). La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels. Revue des maladies respiratoires, 35(4), 357-377. doi:10.1016/j.rmr.2018.02.001
  12. 11. Rosiere, R., Van Woensel, M., Gelbcke, M., Mathieu, V., Hecq, J., Mathivet, T., Vermeersch, M., Van Antwerpen, P., Amighi, K., & Wauthoz, N. (2018). New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation. Molecular pharmaceutics, 15(3), 899-910. doi:10.1021/acs.molpharmaceut.7b00846
    13. << Précédent 1 2 3 4 5 Suivant >>